ArticleAntimicrobial agents and chemotherapy2011

Novel HIV-1 protease inhibitors (PIs) containing a bicyclic P2 functional moiety, tetrahydropyrano-tetrahydrofuran, that are potent against multi-PI-resistant HIV-1 variants.

Kazuhiko Ide et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.